AU2001267885A1 - Use of disease-associated gene - Google Patents
Use of disease-associated geneInfo
- Publication number
- AU2001267885A1 AU2001267885A1 AU2001267885A AU6788501A AU2001267885A1 AU 2001267885 A1 AU2001267885 A1 AU 2001267885A1 AU 2001267885 A AU2001267885 A AU 2001267885A AU 6788501 A AU6788501 A AU 6788501A AU 2001267885 A1 AU2001267885 A1 AU 2001267885A1
- Authority
- AU
- Australia
- Prior art keywords
- disease
- associated gene
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-203104 | 2000-06-30 | ||
JP2000203104 | 2000-06-30 | ||
PCT/JP2001/005652 WO2002003063A1 (en) | 2000-06-30 | 2001-06-29 | Use of disease-associated gene |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001267885A1 true AU2001267885A1 (en) | 2002-01-14 |
Family
ID=18700545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001267885A Abandoned AU2001267885A1 (en) | 2000-06-30 | 2001-06-29 | Use of disease-associated gene |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030108951A1 (en) |
EP (1) | EP1296138A4 (en) |
AU (1) | AU2001267885A1 (en) |
WO (1) | WO2002003063A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9545701A (en) * | 2000-09-11 | 2002-03-22 | Merck Patent Gmbh | Use of carp inhibitors for the treatment of heart diseases |
EP1833986B1 (en) | 2004-12-14 | 2012-05-23 | Sydney West Area Health Service | Determinants of sensitivity to chemotherapeutic agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2344459A1 (en) * | 1998-10-01 | 2000-04-13 | Takeda Chemical Industries, Ltd. | Novel g protein-coupled receptor protein and dna thereof |
WO2001025427A1 (en) * | 1999-10-01 | 2001-04-12 | Kyowa Hakko Kogyo Co., Ltd. | Shear stress-response dna |
-
2001
- 2001-06-29 WO PCT/JP2001/005652 patent/WO2002003063A1/en not_active Application Discontinuation
- 2001-06-29 EP EP01945720A patent/EP1296138A4/en not_active Withdrawn
- 2001-06-29 AU AU2001267885A patent/AU2001267885A1/en not_active Abandoned
- 2001-06-29 US US10/312,064 patent/US20030108951A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1296138A1 (en) | 2003-03-26 |
US20030108951A1 (en) | 2003-06-12 |
WO2002003063A1 (en) | 2002-01-10 |
EP1296138A4 (en) | 2005-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1548401A (en) | Use of disease-associated gene | |
AU2001264247A1 (en) | GASC1 gene | |
AUPQ749100A0 (en) | New epilespy gene | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AU2001285743A1 (en) | Adipose-related gene | |
AU2001267885A1 (en) | Use of disease-associated gene | |
AU2001259595A1 (en) | Haplotypes of the crybb1 gene | |
AU2002315776A1 (en) | Use of disease-associated gene | |
AU2001233702A1 (en) | Disease-associated gene | |
AU2002210960A1 (en) | Novel disease-associated gene and use thereof | |
AU2001281974A1 (en) | Disease-associated gene | |
AU2001295955A1 (en) | Novel disease-associated gene and use thereof | |
AU2002311205A1 (en) | Novel disease-associated gene and use thereof | |
AU2002210985A1 (en) | Pca2501 gene | |
EP1413884A4 (en) | Use of disease-associated gene | |
AU2002328863A1 (en) | Oncosuppressive gene | |
AU2003261911A1 (en) | Use of disease-associated gene | |
AU2003252291A1 (en) | Use of disease-associated gene | |
AU2002239511A1 (en) | Haplotypes of the gsr gene | |
AU2001257050A1 (en) | Haplotypes of the zfp36 gene | |
AU2001274995A1 (en) | Haplotypes of the rlbp1 gene | |
AU2001286644A1 (en) | Haplotypes of the gng7 gene | |
AU2001273117A1 (en) | Haplotypes of the appbp1 gene | |
AU2001249650A1 (en) | Haplotypes of the chrnb3 gene | |
AU2002346158A1 (en) | Gene therapeutics |